Cytomegalovirus infection after liver transplantation using different prophylaxes

Transplant Proc. 2001 Nov-Dec;33(7-8):3624-5. doi: 10.1016/s0041-1345(01)02559-3.

Authors

A Kornberg¹, T Grube, M Hommann, U Schotte, J Scheele

Affiliation

¹ Department of General and Visceral Surgery, Friedrich-Schiller University, Jena, Germany.

PMID: 11750539
DOI: 10.1016/s0041-1345(01)02559-3

No abstract available

MeSH terms

Antiviral Agents / therapeutic use*
Cytomegalovirus / isolation & purification
Cytomegalovirus Infections / epidemiology*
Cytomegalovirus Infections / prevention & control
Drug Therapy, Combination
Ganciclovir / therapeutic use
Graft Rejection / drug therapy
Humans
Immunosuppressive Agents / therapeutic use
Liver Transplantation*
Methylprednisolone / therapeutic use
Monitoring, Physiologic
Phosphoproteins / blood
Postoperative Complications / epidemiology
Postoperative Complications / prevention & control
Postoperative Complications / virology*
Viral Matrix Proteins / blood

Substances

Antiviral Agents
Immunosuppressive Agents
Phosphoproteins
Viral Matrix Proteins
cytomegalovirus matrix protein 65kDa
Ganciclovir
Methylprednisolone